Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2004

View Archived Issues

OSI Pharmaceuticals reports portfolio highlights from Q1 2004

MedImmune highlights 2003 developments

Further evidence for the antiovulatory effects of CDB-2914 in healthy women

Allergan updates Q4 2003 product and pipeline developments

Abbott to evaluate Raven's monoclonal antibodies in new collaboration

EntreMed transfers endostatin and angiostatin rights

Adderall XR available in Canada

Tillotts and Zeria sign Japanese agreement for Asacol

Pharmacopeia and Taiho collaborate on drug discovery efforts

Abbott and Caprion collaborate on drug discovery for lung cancer

The SPORTIF trials provide new data on ximelagatran in the prevention of stroke

First phase I results reported for Ono-2506 in the management of ischemic stroke

Clinical improvements found with CP-101606 in acute ischemic stroke

Phase II clinical results on the efficacy and safety of DP-b99 in acute stroke

Preclinical and clinical evidence of the benefits of repinotan in ischemia

Selective and dual PPARalpha/PPARgamma agonists developed at AstraZeneca

NO-releasing COX-2 inhibitors in early development at NicOx

Another series of HCV NS5B inhibitors presented by Merck and Isis researchers

Novel pyridazine-based PDE4 inhibitors covered by Merck KGaA patent

Lilly presents new selective and dual PPAR modulators

Pfizer claims new MMP-13 inhibitors with utility in inflammatory disorders and cancer

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

New PDE5 inhibitors claimed by Janssen scientists

NanoPass and GlaxoSmithKline to develop MicroPyramid vaccine technology

Nuvelo licenses rNAPc from Dendreon

DepoCyte launched in Europe

New clinical program for maribavir in prevention of CMV in transplants

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Alimta approved for use with cisplatin for malignant pleural mesothelioma

AP-5346 makes preclinical and clinical progress

Orthovisc receives FDA approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...